HALOPERIDOL DECANOATE
Active substance: haloperidol decanoate
INJECTION · HALOPERIDOL DECANOATE 100 mg/mL
United StatesActive
Marketing holder: Somerset Therapeutics, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- HALOPERIDOL DECANOATE · 100 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5783-75ca-886b-b37fe62a3023,01a1208c-8f83-7189-a26d-1afad2506d7c,01a1208d-9fe8-73fd-a4e7-b52bd933a773,01a1208d-a01f-718a-b4e6-51d95764ad5d,01a1208e-1384-7a7c-82e1-c788707d11a4;count=56 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70069-868
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR
Sources
- product · openFDA NDC · 70069-868 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70069-868 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70069-868 · Verified 2026-10-09 · open in source